Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free MNDR Stock Alerts

Mobile-health Network Solutions (MNDR) Competitors

Mobile-health Network Solutions logo
$1.73 +0.09 (+5.17%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$1.72 -0.01 (-0.87%)
As of 08/14/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

MNDR vs. AIDX, NIVF, IVF, BTSGU, and WGSWW

Should you buy Mobile-health Network Solutions stock or one of its competitors? Mobile-health Network Solutions's main competitors and comparable companies include 20/20 Biolabs (AIDX), NewGenIvf Group (NIVF), INVO Fertility (IVF), BrightSpring Health Services (BTSGU), and GeneDx (WGSWW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Mobile-health Network Solutions compare to 20/20 Biolabs?

20/20 Biolabs (NASDAQ:AIDX) and Mobile-health Network Solutions (NASDAQ:MNDR) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

20/20 Biolabs currently has a consensus price target of $5.00, indicating a potential upside of 810.75%. Given 20/20 Biolabs' stronger consensus rating and higher probable upside, analysts clearly believe 20/20 Biolabs is more favorable than Mobile-health Network Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
20/20 Biolabs
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Mobile-health Network Solutions
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Mobile-health Network Solutions has higher revenue and earnings than 20/20 Biolabs.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
20/20 Biolabs$2.05M3.28-$3.74M-$0.28N/A
Mobile-health Network Solutions$7.65M0.19-$3.38MN/AN/A

Company Net Margins Return on Equity Return on Assets
20/20 BiolabsN/A N/A N/A
Mobile-health Network Solutions N/A N/A N/A

In the previous week, 20/20 Biolabs and 20/20 Biolabs both had 3 articles in the media. 20/20 Biolabs' average media sentiment score of 1.32 beat Mobile-health Network Solutions' score of 0.55 indicating that 20/20 Biolabs is being referred to more favorably in the media.

Company Overall Sentiment
20/20 Biolabs Positive
Mobile-health Network Solutions Positive

Summary

20/20 Biolabs beats Mobile-health Network Solutions on 5 of the 7 factors compared between the two stocks.

How does Mobile-health Network Solutions compare to NewGenIvf Group?

Mobile-health Network Solutions (NASDAQ:MNDR) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

In the previous week, Mobile-health Network Solutions had 1 more articles in the media than NewGenIvf Group. MarketBeat recorded 3 mentions for Mobile-health Network Solutions and 2 mentions for NewGenIvf Group. NewGenIvf Group's average media sentiment score of 1.44 beat Mobile-health Network Solutions' score of 0.55 indicating that NewGenIvf Group is being referred to more favorably in the news media.

Company Overall Sentiment
Mobile-health Network Solutions Positive
NewGenIvf Group Positive

Mobile-health Network Solutions has a beta of -0.82, meaning that its stock price is 182% less volatile than the broader market. Comparatively, NewGenIvf Group has a beta of 0.01, meaning that its stock price is 99% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mobile-health Network Solutions
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
NewGenIvf Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Company Net Margins Return on Equity Return on Assets
Mobile-health Network SolutionsN/A N/A N/A
NewGenIvf Group N/A N/A N/A

66.2% of NewGenIvf Group shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

NewGenIvf Group has lower revenue, but higher earnings than Mobile-health Network Solutions.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mobile-health Network Solutions$7.65M0.19-$3.38MN/AN/A
NewGenIvf Group$4.73M0.73$9.88MN/AN/A

Summary

NewGenIvf Group beats Mobile-health Network Solutions on 6 of the 8 factors compared between the two stocks.

How does Mobile-health Network Solutions compare to INVO Fertility?

INVO Fertility (NASDAQ:IVF) and Mobile-health Network Solutions (NASDAQ:MNDR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

12.0% of INVO Fertility shares are held by institutional investors. 0.4% of INVO Fertility shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

INVO Fertility has a beta of 2.32, indicating that its stock price is 132% more volatile than the broader market. Comparatively, Mobile-health Network Solutions has a beta of -0.82, indicating that its stock price is 182% less volatile than the broader market.

Mobile-health Network Solutions has a net margin of 0.00% compared to INVO Fertility's net margin of -183.75%. Mobile-health Network Solutions' return on equity of 0.00% beat INVO Fertility's return on equity.

Company Net Margins Return on Equity Return on Assets
INVO Fertility-183.75% -420.62% -45.21%
Mobile-health Network Solutions N/A N/A N/A

In the previous week, Mobile-health Network Solutions had 1 more articles in the media than INVO Fertility. MarketBeat recorded 3 mentions for Mobile-health Network Solutions and 2 mentions for INVO Fertility. Mobile-health Network Solutions' average media sentiment score of 0.55 beat INVO Fertility's score of 0.46 indicating that Mobile-health Network Solutions is being referred to more favorably in the news media.

Company Overall Sentiment
INVO Fertility Neutral
Mobile-health Network Solutions Positive

INVO Fertility currently has a consensus price target of $20.00, indicating a potential upside of 1,958.46%. Given INVO Fertility's stronger consensus rating and higher possible upside, equities research analysts plainly believe INVO Fertility is more favorable than Mobile-health Network Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INVO Fertility
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
Mobile-health Network Solutions
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Mobile-health Network Solutions has higher revenue and earnings than INVO Fertility.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INVO Fertility$6.84M0.33-$25.13M-$352.18N/A
Mobile-health Network Solutions$7.65M0.19-$3.38MN/AN/A

Summary

INVO Fertility and Mobile-health Network Solutions tied by winning 7 of the 14 factors compared between the two stocks.

How does Mobile-health Network Solutions compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSGU) and Mobile-health Network Solutions (NASDAQ:MNDR) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

BrightSpring Health Services has higher revenue and earnings than Mobile-health Network Solutions.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$14.37BN/AN/AN/AN/A
Mobile-health Network Solutions$7.65M0.19-$3.38MN/AN/A

Company Net Margins Return on Equity Return on Assets
BrightSpring Health ServicesN/A N/A N/A
Mobile-health Network Solutions N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Mobile-health Network Solutions
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Mobile-health Network Solutions had 1 more articles in the media than BrightSpring Health Services. MarketBeat recorded 3 mentions for Mobile-health Network Solutions and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.43 beat Mobile-health Network Solutions' score of 0.55 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Overall Sentiment
BrightSpring Health Services Positive
Mobile-health Network Solutions Positive

Summary

BrightSpring Health Services beats Mobile-health Network Solutions on 3 of the 4 factors compared between the two stocks.

How does Mobile-health Network Solutions compare to GeneDx?

GeneDx (NASDAQ:WGSWW) and Mobile-health Network Solutions (NASDAQ:MNDR) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

Company Net Margins Return on Equity Return on Assets
GeneDxN/A N/A N/A
Mobile-health Network Solutions N/A N/A N/A

GeneDx has higher revenue and earnings than Mobile-health Network Solutions.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GeneDx$442.68MN/AN/AN/AN/A
Mobile-health Network Solutions$7.65M0.19-$3.38MN/AN/A

In the previous week, Mobile-health Network Solutions had 3 more articles in the media than GeneDx. MarketBeat recorded 3 mentions for Mobile-health Network Solutions and 0 mentions for GeneDx. Mobile-health Network Solutions' average media sentiment score of 0.55 beat GeneDx's score of 0.00 indicating that Mobile-health Network Solutions is being referred to more favorably in the news media.

Company Overall Sentiment
GeneDx Neutral
Mobile-health Network Solutions Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GeneDx
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Mobile-health Network Solutions
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Mobile-health Network Solutions beats GeneDx on 3 of the 4 factors compared between the two stocks.

Get Mobile-health Network Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNDR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MNDR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MNDR vs. The Competition

Export
MetricMobile-health Network SolutionsHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.47M$9.87B$7.03B$13.07B
Dividend YieldN/A2.54%2.57%10.65%
P/E RatioN/A35.17271.2625.38
Price / Sales0.194.88623.44105.58
Price / CashN/A124.2475.7053.27
Price / Book0.123.9412.926.21
Net Income-$3.38M$309.96M$3.45B$347.71M
7 Day Performance-2.26%0.09%1.16%1.08%
1 Month Performance-47.89%-0.34%2.17%1.87%
1 Year Performance-99.12%19.48%62.38%20.79%

Mobile-health Network Solutions Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MNDR
Mobile-health Network Solutions
0.52 of 5 stars		$1.73
+5.2%		N/A-99.1%$1.47M$7.65MN/AN/A
AIDX
20/20 Biolabs
2.7525 of 5 stars		$0.46
+6.0%		$5.00
+984.6%		N/A$5.33M$2.05MN/A14
NIVF
NewGenIvf Group
2.9279 of 5 stars		$0.52
+0.7%		N/A-99.8%$3.08M$4.73MN/AN/A
IVF
INVO Fertility
2.3337 of 5 stars		$1.01
-1.9%		$20.00
+1,880.2%		-98.5%$2.36M$6.84MN/A10
BTSGU
BrightSpring Health Services
N/A$198.07
+4.1%		N/A+160.0%$0.00$14.37BN/A35,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MNDR) was last updated on 8/16/2026 by MarketBeat.com Staff.
From Our Partners
The Greatest Wealth Transfer Since the Internet Boom Just Started
Wall Street forensic accountant Joel Litman - who flagged the 2008 crash months early and called the 2020 COVI...
Altimetry | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your 10X AI demo is starting…
Keith Kaplan, the AI expert behind tools used by more than 100000 investors, built his models with an investme...
TradeSmith | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel